Cleared Traditional

K020213 - NETLINK/NETSCAN

K020213 is the FDA 510(k) clearance for NETLINK/NETSCAN by Rozinn Electronics, Inc.. It is a Class 2 Cardiovascular device (product code DXH) cleared through the Traditional 510(k) pathway after a 73-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2002
Decision
73d
Days
Class 2
Risk

K020213 is an FDA 510(k) clearance for the NETLINK/NETSCAN. Classified as Transmitters And Receivers, Electrocardiograph, Telephone (product code DXH), Class II - Special Controls.

Submitted by Rozinn Electronics, Inc. (Glendale, US). The FDA issued a Cleared decision on April 5, 2002 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2920 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Rozinn Electronics, Inc. devices

Submission Details

510(k) Number K020213 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2002
Decision Date April 05, 2002
Days to Decision 73 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 125d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXH Transmitters And Receivers, Electrocardiograph, Telephone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXH Transmitters And Receivers, Electrocardiograph, Telephone

All 93
Devices cleared under the same product code (DXH) and FDA review panel - the closest regulatory comparables to K020213.
PMP4 SELFCHECK ECG
K042254 · Card Guard Scientific Survival , Ltd. · Jan 2005
CG-500 PMP PERSONAL MEDICAL PHONE SYSTEM
K023689 · Card Guard Scientific Survival , Ltd. · Jan 2003
TM2005 PERSONAL MEDICAL PHONE CENTER
K024365 · Card Guard Scientific Survival , Ltd. · Jan 2003
TM2000, MODEL 1
K013879 · Card Guard Scientific Survival , Ltd. · Feb 2002
TM2000 EASYTRACE PLUS RECEIVING CENTER
K013175 · Card Guard Scientific Survival , Ltd. · Oct 2001
CG-2211 SELFCHECK ECG TRANSMITTER
K012223 · Card Guard Scientific Survival , Ltd. · Sep 2001